Lindbrook Capital’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-86
Closed -$1.19K 2793
2023
Q2
$1.19K Sell
86
-11
-11% -$165 ﹤0.01% 2333
2023
Q1
$1.57K Hold
97
﹤0.01% 2340
2022
Q4
$1.72K Sell
97
-361
-79% -$7.17K ﹤0.01% 2297
2022
Q3
$9K Buy
458
+198
+76% +$4.2K ﹤0.01% 1385
2022
Q2
$5K Sell
260
-139
-35% -$3.11K ﹤0.01% 1561
2022
Q1
$10K Buy
399
+302
+311% +$7.83K ﹤0.01% 1284
2021
Q4
$2K Hold
97
﹤0.01% 1809
2021
Q3
$3K Hold
97
﹤0.01% 1431
2021
Q2
$3K Sell
97
-15
-13% -$476 ﹤0.01% 1494
2021
Q1
$4K Buy
112
+15
+15% +$522 ﹤0.01% 1347
2020
Q4
$3K Hold
97
﹤0.01% 1363
2020
Q3
$3K Hold
97
﹤0.01% 1297
2020
Q2
$3K Hold
97
﹤0.01% 1284
2020
Q1
$3K Hold
97
﹤0.01% 1217
2019
Q4
$2K Hold
97
﹤0.01% 1312
2019
Q3
$2K Sell
97
-33
-25% -$545 ﹤0.01% 1291
2019
Q2
$2K Hold
130
﹤0.01% 1256
2019
Q1
$2K Hold
130
﹤0.01% 1252
2018
Q4
$3K Buy
+130
New +$3.47K ﹤0.01% 1123

Other funds holding PETS

Lindbrook Capital's PETS Position: Q3 2023 in Review

Lindbrook Capital sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 86 shares — an estimated $1.19K sold.

Lindbrook Capital first reported a position in PETS in Q4 2018 and held it in 19 quarters. The position peaked at $10K in Q1 2022. 138 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • Lindbrook Capital reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • Lindbrook Capital sold 86 PetMed Express shares in Q3 2023, an estimated $1.19K.
  • Lindbrook Capital first reported a position in PetMed Express in Q4 2018 and held it in 19 quarters.
  • Lindbrook Capital's PetMed Express position peaked at $10K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.